#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	466	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1103	22.6	0	.	p	.	0	K29T	NONSYN	85	87	AAG	281	283	ACG	25;26;26	A;C;G	25;26;26	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	280	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	159	18.5	0	.	n	.	0	T879G	SNP	879	879	T	35	35	G	2	G	2	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	280	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	159	18.5	0	.	n	.	0	G880A	SNP	880	880	G	36	36	A	2	A	2	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	280	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	159	18.5	0	.	n	.	0	A888G	SNP	888	888	A	44	44	G	2	G	2	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	280	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	159	18.5	0	.	n	.	0	C897G	SNP	897	897	C	53	53	G	4	G	4	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	280	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	159	18.5	0	.	n	.	0	T898C	SNP	898	898	T	54	54	C	5	C	5	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	280	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	159	18.5	0	.	n	.	0	G906T	SNP	906	906	G	62	62	T	11	T	11	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	280	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	159	18.5	0	.	n	.	0	G908A	SNP	908	908	G	64	64	A	14	A	14	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	280	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	159	18.5	0	.	n	.	0	A918T	SNP	918	918	A	74	74	T	16	T	16	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	280	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	159	18.5	0	.	n	.	0	A943G	SNP	943	943	A	99	99	G	50	G	50	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	280	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	159	18.5	0	.	n	.	0	G991T	SNP	991	991	G	147	147	T	29	T	29	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1964	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1647	62.6	0	.	p	.	0	G409S	NONSYN	1225	1227	GGC	1453	1455	AGC	41;41;41	A,G;G;C	31,10;41;41	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1964	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1647	62.6	1	SNP	p	R234F	1	.	.	700	702	TTC	928	930	TTC	96;98;96	T;T;C	95;97;94	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1964	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1647	62.6	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1228	1230	CGT	80;84;83	C;G;T	80;83;83	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1964	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1647	62.6	0	HET	.	.	.	T999C	.	999	999	T	1227	1227	T	79	T,C	52,27	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1964	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1647	62.6	0	HET	.	.	.	C255T	.	255	255	C	483	483	C	91	C,T	46,45	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1964	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1647	62.6	0	HET	.	.	.	T180C	.	180	180	T	408	408	T	51	T,C	27,22	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	552	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c4.ctg.1	1729	17.0	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1511	1513	AAA	4;4;5	A;A;A	4;4;5	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	942	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1753	28.8	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1249	1251	GAA	28;29;29	G;A;A	28;29;28	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	140	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	538	12.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	652	PmrB_1	1092	1092	99.08	PmrB_1.l6.c30.ctg.1	1436	24.2	0	.	p	.	0	H2R	NONSYN	4	6	CAT	194	196	CGT	21;22;23	C;G;T	21;22;22	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	652	PmrB_1	1092	1092	99.08	PmrB_1.l6.c30.ctg.1	1436	24.2	0	.	p	.	0	V30I	NONSYN	88	90	GTC	278	280	ATC	20;20;21	A;T;C	20;20;21	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	652	PmrB_1	1092	1092	99.08	PmrB_1.l6.c30.ctg.1	1436	24.2	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1037	1039	GGC	26;26;25	G;G;C	26;25;25	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	846	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	1907	23.7	0	.	p	.	0	R8S	NONSYN	22	24	AGA	56	58	AGC	2;3;3	A;G;C	2;3;3	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	846	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	1907	23.7	0	.	p	.	0	I142L	NONSYN	424	426	ATA	458	460	CTA	18;19;18	C;T;A	18;19;18	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	846	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	1907	23.7	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	977	979	CAA	25;25;25	C;A;A	25;25;25	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	846	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	1907	23.7	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1076	1078	GGT	44;47;46	G;G;T	44;47;46	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	846	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	1907	23.7	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1646	1648	GTT	11;11;10	G;T;T	11;11;10	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	310	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1362	11.9	0	.	p	.	0	A125E	NONSYN	373	375	GCA	512	514	GAA	12;11;11	G;A;A	12;11;11	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	310	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1362	11.9	0	.	p	.	0	M185T	NONSYN	553	555	ATG	692	694	ACC	4;4;4	A;C;C	4;4;4	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	310	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1362	11.9	0	.	p	.	0	S225T	NONSYN	673	675	TCC	812	814	ACT	12;12;9	A;C;T	12;12;9	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	310	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1362	11.9	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1202	1204	ATC	14;14;14	A;T;C	14;14;14	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	470	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1385	18.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	38	TEM_1+	858	171	98.83	TEM_1+.l15.c30.ctg.1	171	3.2	0	.	p	.	0	F19L	NONSYN	55	57	TTT	8	10	CTT	1;1;1	C;T;T	1;1;1	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	38	TEM_1+	858	180	100.0	TEM_1+.l15.c30.ctg.2	180	2.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1678	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3529	25.4	0	.	p	.	0	T85I	NONSYN	253	255	ACC	455	457	ATC	28;30;30	A;T;C	28;30;30	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1678	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3529	25.4	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2168	2170	AAG	8;8;8	A;A;G	8;8;8	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	728	acrE	1158	1158	98.79	acrE.l6.c4.ctg.1	1492	26.2	0	.	p	.	0	A22V	NONSYN	64	66	GCC	244	246	GTC	7;7;7	G;T;C	7;7;7	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	728	acrE	1158	1158	98.79	acrE.l6.c4.ctg.1	1492	26.2	0	.	p	.	0	S269C	NONSYN	805	807	AGC	985	987	TGC	27;28;28	T;G;C	27;28;28	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1806	acrF	3105	3105	98.52	acrF.l6.c30.ctg.1	3368	28.6	0	.	p	.	0	S46trunc	TRUNC	136	136	T	326	326	T	12	T	12	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1806	acrF	3105	3105	98.52	acrF.l6.c30.ctg.1	3368	28.6	0	.	p	.	0	G148D	NONSYN	442	444	GGC	632	634	GAC	23;23;22	G;A;C	23;23;22	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1806	acrF	3105	3105	98.52	acrF.l6.c30.ctg.1	3368	28.6	0	.	p	.	0	F240L	NONSYN	718	720	TTT	908	910	TTA	7;6;6	T;T;A	7;6;6	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1806	acrF	3105	3105	98.52	acrF.l6.c30.ctg.1	3368	28.6	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1091	1093	AAT	22;22;21	A;A;T	22;22;21	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1806	acrF	3105	3105	98.52	acrF.l6.c30.ctg.1	3368	28.6	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1878	1878	T	50	T	50	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	330	acrR_2	648	648	99.54	acrR_2.l6.c4.ctg.1	1000	17.7	1	SNP	p	R45C	0	.	.	133	135	CGC	296	298	CGC	29;28;29	C;G;C	29;28;29	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	244	acrS	663	663	98.64	acrS.l15.c30.ctg.1	934	13.9	0	.	p	.	0	L34F	NONSYN	100	102	CTC	196	198	TTC	14;14;13	T,C;T;C	13,1;14;13	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	244	acrS	663	663	98.64	acrS.l15.c30.ctg.1	934	13.9	0	.	p	.	0	E122G	NONSYN	364	366	GAG	460	462	GGG	14;14;14	G;G;G	14;14;14	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	376	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1134	17.8	0	.	p	.	0	V136L	NONSYN	406	408	GTT	587	589	CTT	25;25;24	C;T;T	25;25;24	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1934	alaS	2631	2631	98.9	alaS.l15.c4.ctg.1	3000	34.5	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2030	2032	GCA	52;52;52	G;C;A	52;52;52	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1934	alaS	2631	2631	98.9	alaS.l15.c4.ctg.1	3000	34.5	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2291	2293	ACC	34;35;36	A;C;C	33;33;35	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1934	alaS	2631	2631	98.9	alaS.l15.c4.ctg.1	3000	34.5	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2600	2602	GCC	25;23;22	G;C;C	25;22;22	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	528	770	arnA_1	1983	1750	98.46	arnA_1.l15.c30.ctg.1	1922	20.3	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	32	34	TGC	7;7;8	T;G;C	7;7;8	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	528	770	arnA_1	1983	1750	98.46	arnA_1.l15.c30.ctg.1	1922	20.3	0	.	p	.	0	I150V	NONSYN	448	450	ATT	215	217	GTT	18;18;18	G;T;T	18;18;18	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	528	770	arnA_1	1983	1750	98.46	arnA_1.l15.c30.ctg.1	1922	20.3	0	.	p	.	0	R200H	NONSYN	598	600	CGC	365	367	CAC	20;20;20	C;A;C	20;20;20	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	528	770	arnA_1	1983	1750	98.46	arnA_1.l15.c30.ctg.1	1922	20.3	0	.	p	.	0	T295M	NONSYN	883	885	ACG	650	652	ATG	25;26;27	A;T;G	24;24;27	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	528	770	arnA_1	1983	1750	98.46	arnA_1.l15.c30.ctg.1	1922	20.3	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1646	1648	CGC	11;12;12	C;G;C	11;12;12	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	531	322	bacA	822	815	98.53	bacA.l15.c30.ctg.1	992	16.2	0	.	p	.	0	S221T	NONSYN	661	663	AGC	838	840	ACC	8;8;7	A;C;C	8;8;7	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	531	322	bacA	822	815	98.53	bacA.l15.c30.ctg.1	992	16.2	0	.	p	.	0	P225S	NONSYN	673	675	CCG	850	852	TCG	12;13;13	T;C;G	12;13;13	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	384	baeR	723	723	97.79	baeR.l15.c4.ctg.1	1088	18.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	564	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1608	18.1	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1317	1319	AAA	11;11;12	A;A;A	11;11;12	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	564	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1608	18.1	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1329	1331	GAG	9;9;10	G;A;G	9;8;9	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	564	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1608	18.1	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1335	1337	CAC	11;11;10	C;A;C	10;10;9	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	564	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1608	18.1	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1389	1391	GAG	15;15;16	G;A;G	15;15;16	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	828	cpxA	1374	1374	98.91	cpxA.l15.c17.ctg.1	1839	24.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	540	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1136	25.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	378	cysB	975	975	99.28	cysB.l6.c4.ctg.1	1112	17.8	0	.	p	.	0	A146T	NONSYN	436	438	GCT	467	469	ACT	24;22;22	A;C;T	24;22;22	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	640	emrA	1173	1173	98.29	emrA.l6.c17.ctg.1	1633	20.9	0	.	p	.	0	I219V	NONSYN	655	657	ATC	867	869	GTC	47;47;43	G;T;C	46;45;43	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1012	emrB	1539	1539	99.74	emrB.l15.c30.ctg.1	2025	26.7	0	.	p	.	0	E197K	NONSYN	589	591	GAA	849	851	AAA	33;34;34	A;A;A	33;34;34	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	722	emrD	1191	1191	98.4	emrD.l6.c4.ctg.1	1707	22.7	0	.	p	.	0	G209S	NONSYN	625	627	GGC	888	890	AGC	20;20;20	A;G;C	20;20;20	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	20	emrE_1	333	139	92.81	emrE_1.l15.c30.ctg.1	139	3.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	392	emrK	1056	1056	98.2	emrK.l6.c4.ctg.1	1481	14.1	0	.	p	.	0	K176R	NONSYN	526	528	AAG	730	732	AGG	11;11;10	A;G;G	10;10;10	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	392	emrK	1056	1056	98.2	emrK.l6.c4.ctg.1	1481	14.1	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1120	1122	GAC	7;7;6	G;A;C	7;7;6	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	308	emrR	531	531	100.0	emrR.l6.c30.ctg.1	958	17.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	19	484	emrY	1539	1538	99.8	emrY.l6.c4.ctg.1	1858	13.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	228	evgA	615	615	99.19	evgA.l15.c4.ctg.1	857	13.9	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	266	268	CTG	16;15;14	C;T;G	16;15;14	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1120	evgS	3594	860	97.33	evgS.l15.c30.ctg.1	1052	10.5	0	.	p	.	0	T38I	NONSYN	112	114	ACA	304	306	ATA	7;7;7	A;T;A	7;7;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1120	evgS	3594	860	97.33	evgS.l15.c30.ctg.1	1052	10.5	0	.	p	.	0	L42V	NONSYN	124	126	CTA	316	318	GTA	4;4;4	G;T;A	4;4;4	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1120	evgS	3594	860	97.33	evgS.l15.c30.ctg.1	1052	10.5	0	.	p	.	0	A93T	NONSYN	277	279	GCG	469	471	ACG	7;7;8	A;C;G	7;7;8	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1120	evgS	3594	860	97.33	evgS.l15.c30.ctg.1	1052	10.5	0	.	p	.	0	A114E	NONSYN	340	342	GCA	532	534	GAA	10;10;10	G;A;A	10;10;10	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1120	evgS	3594	860	97.33	evgS.l15.c30.ctg.1	1052	10.5	0	.	p	.	0	T127A	NONSYN	379	381	ACT	571	573	GCT	11;11;11	G;C;T	11;11;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1120	evgS	3594	860	97.33	evgS.l15.c30.ctg.1	1052	10.5	0	.	p	.	0	N133D	NONSYN	397	399	AAT	589	591	GAT	12;11;11	G;A;T	12;11;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1120	evgS	3594	860	97.33	evgS.l15.c30.ctg.1	1052	10.5	0	.	p	.	0	P162S	NONSYN	484	486	CCA	676	678	TCA	14;14;14	T;C;A	14;14;14	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1120	evgS	3594	860	97.33	evgS.l15.c30.ctg.1	1052	10.5	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	805	807	CAG	6;6;6	C;A;G	6;6;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1120	evgS	3594	860	97.33	evgS.l15.c30.ctg.1	1052	10.5	0	.	p	.	0	I251V	NONSYN	751	753	ATT	943	945	GTT	5;4;4	G;T;T	5;4;4	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1120	evgS	3594	2477	97.9	evgS.l15.c30.ctg.2	2498	18.5	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	180	182	AAA	10;12;12	A;A;A	10;12;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1120	evgS	3594	2477	97.9	evgS.l15.c30.ctg.2	2498	18.5	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	915	917	CAT	12;12;12	C;A;T	12;12;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1120	evgS	3594	2477	97.9	evgS.l15.c30.ctg.2	2498	18.5	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	969	971	CAT	12;12;13	C;A;T	12;12;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1120	evgS	3594	2477	97.9	evgS.l15.c30.ctg.2	2498	18.5	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	987	989	AGA	8;9;9	A;G;A	8;9;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1120	evgS	3594	2477	97.9	evgS.l15.c30.ctg.2	2498	18.5	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1002	1004	AAT	11;13;13	A;A;T	11;13;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1120	evgS	3594	2477	97.9	evgS.l15.c30.ctg.2	2498	18.5	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1149	1151	TCC	10;10;10	T;C;C	10;9;10	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1120	evgS	3594	2477	97.9	evgS.l15.c30.ctg.2	2498	18.5	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1314	1316	ATT	16;16;15	A;T;T	16;16;15	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1120	evgS	3594	2477	97.9	evgS.l15.c30.ctg.2	2498	18.5	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1335	1337	GAT	10;12;13	G;A;T	10;12;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1120	evgS	3594	2477	97.9	evgS.l15.c30.ctg.2	2498	18.5	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1449	1451	GTT	14;13;13	G;T;T	14;13;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1120	evgS	3594	2477	97.9	evgS.l15.c30.ctg.2	2498	18.5	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1734	1736	CAC	12;12;11	C;A;C	12;12;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1120	evgS	3594	141	97.16	evgS.l15.c30.ctg.3	153	7.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	476	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1391	18.5	1	SNP	p	P64R	0	.	.	190	192	CCA	457	459	CCA	43;43;43	C;C;A	43;43;41	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	476	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1391	18.5	1	SNP	p	P64H	0	.	.	190	192	CCA	457	459	CCA	43;43;43	C;C;A	43;43;41	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	476	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1391	18.5	1	SNP	p	P64L	0	.	.	190	192	CCA	457	459	CCA	43;43;43	C;C;A	43;43;41	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	476	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1391	18.5	1	SNP	p	P64A	0	.	.	190	192	CCA	457	459	CCA	43;43;43	C;C;A	43;43;41	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	476	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1391	18.5	1	SNP	p	P64S	0	.	.	190	192	CCA	457	459	CCA	43;43;43	C;C;A	43;43;41	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	196	gadE	528	528	100.0	gadE.l15.c30.ctg.1	730	13.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	74	gadW	729	122	97.54	gadW.l15.c4.ctg.1	123	14.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	74	gadW	729	129	95.35	gadW.l15.c4.ctg.3	129	4.2	0	.	p	.	0	K110N	NONSYN	328	330	AAA	4	6	AAT	1;1;1	A;A;T	1;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	258	gadX	825	825	98.0	gadX.l15.c4.ctg.1	849	14.9	0	.	p	.	0	F53L	NONSYN	157	159	TTC	132	134	TTA	12;12;12	T;T;A	12;12;12	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	258	gadX	825	825	98.0	gadX.l15.c4.ctg.1	849	14.9	0	.	p	.	0	V79I	NONSYN	235	237	GTT	210	212	ATT	7;7;7	A;T;T	7;7;7	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	258	gadX	825	825	98.0	gadX.l15.c4.ctg.1	849	14.9	0	.	p	.	0	R246G	NONSYN	736	738	AGA	711	713	GGA	20;19;19	G;G;A	20;19;19	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	258	gadX	825	825	98.0	gadX.l15.c4.ctg.1	849	14.9	0	.	p	.	0	S248P	NONSYN	742	744	TCG	717	719	CCG	19;19;21	C;C;G	19;19;21	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1588	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3115	27.3	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2322	2324	GAA	31;29;31	G;A;A	31;28;31	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1588	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3115	27.3	1	SNP	p	S83W	0	.	.	247	249	TCG	537	539	TCG	27;27;27	T;C;G	27;27;27	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1588	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3115	27.3	1	SNP	p	S83L	0	.	.	247	249	TCG	537	539	TCG	27;27;27	T;C;G	27;27;27	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1588	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3115	27.3	1	SNP	p	S83I	0	.	.	247	249	TCG	537	539	TCG	27;27;27	T;C;G	27;27;27	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1588	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3115	27.3	1	SNP	p	D87H	0	.	.	259	261	GAC	549	551	GAC	22;21;21	G;A;C	22;19;21	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1588	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3115	27.3	1	SNP	p	D87G	0	.	.	259	261	GAC	549	551	GAC	22;21;21	G;A;C	22;19;21	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1588	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3115	27.3	1	SNP	p	D87N	0	.	.	259	261	GAC	549	551	GAC	22;21;21	G;A;C	22;19;21	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1588	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3115	27.3	1	SNP	p	D87Y	0	.	.	259	261	GAC	549	551	GAC	22;21;21	G;A;C	22;19;21	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1588	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3115	27.3	1	SNP	p	D87V	0	.	.	259	261	GAC	549	551	GAC	22;21;21	G;A;C	22;19;21	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1502	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2763	28.9	1	SNP	p	R136C	0	.	.	406	408	CGC	614	616	CGC	26;28;27	C;G;C	26;28;27	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1502	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2763	28.9	1	SNP	p	R136S	0	.	.	406	408	CGC	614	616	CGC	26;28;27	C;G;C	26;28;27	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1502	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2763	28.9	1	SNP	p	R136E	0	.	.	406	408	CGC	614	616	CGC	26;28;27	C;G;C	26;28;27	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1502	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2763	28.9	1	SNP	p	R136I	0	.	.	406	408	CGC	614	616	CGC	26;28;27	C;G;C	26;28;27	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1502	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2763	28.9	1	SNP	p	R136G	0	.	.	406	408	CGC	614	616	CGC	26;28;27	C;G;C	26;28;27	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1502	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2763	28.9	1	SNP	p	R136L	0	.	.	406	408	CGC	614	616	CGC	26;28;27	C;G;C	26;28;27	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1502	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2763	28.9	1	SNP	p	R136H	0	.	.	406	408	CGC	614	616	CGC	26;28;27	C;G;C	26;28;27	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	242	kdpE	678	678	98.23	kdpE.l6.c30.ctg.1	956	13.3	0	.	p	.	0	A72P	NONSYN	214	216	GCG	414	416	CCG	21;22;24	C;C;G	21;22;24	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	242	kdpE	678	678	98.23	kdpE.l6.c30.ctg.1	956	13.3	0	.	p	.	0	T123A	NONSYN	367	369	ACC	567	569	GCC	10;9;9	G;C;C	10;9;9	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	522	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1289	21.8	0	.	p	.	0	P9S	NONSYN	25	27	CCA	195	197	TCA	17;18;20	T;C;A	17;18;19	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	168	marA	384	384	99.74	marA.l15.c4.ctg.1	787	11.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	90	marR	435	435	97.7	marR.l6.c30.ctg.1	701	6.7	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	533	535	AGC	5;5;5	A;G;C	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	90	marR	435	435	97.7	marR.l6.c30.ctg.1	701	6.7	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	635	637	CAT	2;2;2	C;A;T	2;2;2	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	90	marR	435	435	97.7	marR.l6.c30.ctg.1	701	6.7	1	SNP	p	V45E	0	.	.	133	135	GTG	359	361	GTG	13;13;13	G;T;G	13;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	90	marR	435	435	97.7	marR.l6.c30.ctg.1	701	6.7	1	SNP	p	I49S	0	.	.	145	147	ATC	371	373	ATC	13;13;13	A;T;C	13;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	90	marR	435	435	97.7	marR.l6.c30.ctg.1	701	6.7	1	SNP	p	A70T	0	.	.	208	210	GCA	434	436	GCA	12;12;12	G;C;A	12;12;11	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	90	marR	435	435	97.7	marR.l6.c30.ctg.1	701	6.7	1	SNP	p	R73C	0	.	.	217	219	CGT	443	445	CGT	13;13;13	C;G;T	13;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	90	marR	435	435	97.7	marR.l6.c30.ctg.1	701	6.7	1	SNP	p	R73S	0	.	.	217	219	CGT	443	445	CGT	13;13;13	C;G;T	13;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	90	marR	435	435	97.7	marR.l6.c30.ctg.1	701	6.7	1	SNP	p	R77C	0	.	.	229	231	CGC	455	457	CGC	11;10;10	C;G;C	11;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	90	marR	435	435	97.7	marR.l6.c30.ctg.1	701	6.7	1	SNP	p	R77L	0	.	.	229	231	CGC	455	457	CGC	11;10;10	C;G;C	11;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	90	marR	435	435	97.7	marR.l6.c30.ctg.1	701	6.7	1	SNP	p	L78M	0	.	.	232	234	CTG	458	460	CTG	9;9;9	C;T;G	9;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	90	marR	435	435	97.7	marR.l6.c30.ctg.1	701	6.7	1	SNP	p	R94H	0	.	.	280	282	CGC	506	508	CGC	4;4;4	C;G;C	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	90	marR	435	435	97.7	marR.l6.c30.ctg.1	701	6.7	1	SNP	p	R94S	0	.	.	280	282	CGC	506	508	CGC	4;4;4	C;G;C	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	90	marR	435	435	97.7	marR.l6.c30.ctg.1	701	6.7	1	SNP	p	V96E	0	.	.	286	288	GTA	512	514	GTA	4;4;4	G;T;A	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	428	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1481	15.3	0	.	p	.	0	S7F	NONSYN	19	21	TCC	45	47	TTC	4;4;4	T;T;C	4;4;4	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	428	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1481	15.3	0	.	p	.	0	R36I	NONSYN	106	108	AGG	132	134	ATC	7;7;7	A;T;C	7;7;7	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	428	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1481	15.3	0	.	p	.	0	E42A	NONSYN	124	126	GAA	150	152	GCC	1;1;1	G;C;C	1;1;1	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	428	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1481	15.3	0	.	p	.	0	N43V	NONSYN	127	129	AAT	153	155	GTG	1;2;2	G;T;G	1;2;2	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	428	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1481	15.3	0	.	p	.	0	E52D	NONSYN	154	156	GAG	180	182	GAT	5;6;6	G;A;T	5;6;6	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	428	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1481	15.3	0	.	p	.	0	N59T	NONSYN	175	177	AAC	201	203	ACC	9;9;9	A;C;C	9;8;8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	428	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1481	15.3	0	.	p	.	0	I68L	NONSYN	202	204	ATA	228	230	TTA	9;9;7	T;T;A	9;9;7	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	428	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1481	15.3	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	369	371	CAG	29;31;32	C;A;G	29;31;32	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	428	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1481	15.3	0	.	p	.	0	D128A	NONSYN	382	384	GAC	408	410	GCC	17;18;21	G;C;C	17;18;21	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	428	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1481	15.3	0	.	p	.	0	S163A	NONSYN	487	489	TCG	513	515	GCG	15;15;16	G;C;G	15;15;16	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	428	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1481	15.3	0	.	p	.	0	L231V	NONSYN	691	693	CTT	717	719	GTT	16;17;17	G,T;T;T	13,1;16;14	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	428	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1481	15.3	0	.	p	.	0	R285fs	FSHIFT	853	853	C	879	879	C	15	C	15	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	531	430	mdtA	1248	1244	97.43	mdtA.l15.c17.ctg.1	1390	15.7	0	.	p	.	0	V12trunc	TRUNC	34	34	G	30	30	G	11	G	11	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	531	430	mdtA	1248	1244	97.43	mdtA.l15.c17.ctg.1	1390	15.7	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	87	89	CAG	13;12;11	C;A;G	13;12;11	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	531	430	mdtA	1248	1244	97.43	mdtA.l15.c17.ctg.1	1390	15.7	0	.	p	.	0	T83I	NONSYN	247	249	ACC	237	239	ATC	6;6;6	A;T;C	6;6;6	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	531	430	mdtA	1248	1244	97.43	mdtA.l15.c17.ctg.1	1390	15.7	0	.	p	.	0	I99M	NONSYN	295	297	ATA	285	287	ATG	7;7;9	A;T;G	7;7;9	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	531	430	mdtA	1248	1244	97.43	mdtA.l15.c17.ctg.1	1390	15.7	0	.	p	.	0	A130T	NONSYN	388	390	GCC	378	380	ACC	13;13;13	A;C;C	13;13;13	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1740	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3476	26.9	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1963	1965	ACC	38;37;37	A;C;C	37;37;37	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1740	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3476	26.9	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2356	2358	CAA	15;15;15	C;A;A	15;14;15	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1740	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3476	26.9	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2524	2526	ATT	24;24;23	A;T;T	24;24;23	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1740	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3476	26.9	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2608	2610	GTT	26;27;27	G;T;T	26;26;27	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1740	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3476	26.9	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2716	2718	GAG	22;22;24	G;A;G	22;22;24	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1740	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3476	26.9	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2944	2946	ATG	19;19;20	A;T;G	19;19;20	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1740	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3476	26.9	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3079	3081	GAT	32;31;29	G;A;T	32;31;29	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1494	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3034	25.4	0	.	p	.	0	I46M	NONSYN	136	138	ATC	72	74	ATG	12;13;12	A;T;G	12;13;12	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1494	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3034	25.4	0	.	p	.	0	V208I	NONSYN	622	624	GTC	558	560	ATC	29;30;31	A;T;C	28;30;31	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1494	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3034	25.4	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	2874	2876	CAC	3;3;4	C;A;C	3;3;4	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1494	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3034	25.4	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	2877	2879	CTC	4;3;3	C;T;C	4;3;3	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	644	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1824	18.9	0	.	p	.	0	D3E	NONSYN	7	9	GAT	186	188	GAA	10;10;9	G;A;A	10;10;9	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	644	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1824	18.9	0	.	p	.	0	T226A	NONSYN	676	678	ACG	855	857	GCG	25;25;26	G;C;G	25;25;26	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	644	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1824	18.9	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1197	1199	ATC	23;23;26	A;T;C	23;23;26	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	644	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1824	18.9	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1500	1502	TTT	22;22;20	T;T;T	22;22;20	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	824	mdtE	1158	1158	99.31	mdtE.l15.c17.ctg.1	1639	26.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2018	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3618	29.9	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1151	1153	ACC	16;16;16	A;C,A;C	16;11,1;15	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2018	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3618	29.9	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2393	2395	GAC	33;32;32	G;A;C	32;30;32	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	564	mdtG	1227	1047	99.43	mdtG.l15.c30.ctg.1	1452	17.3	0	.	p	.	0	V200I	NONSYN	598	600	GTC	606	608	ATC	19;19;19	A;T;C	19;19;19	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	564	mdtG	1227	182	99.45	mdtG.l15.c30.ctg.3	394	9.7	0	.	p	.	0	E5G	NONSYN	13	15	GAA	216	218	GGA	5;5;5	G;G;A	5;5;5	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	572	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1578	19.4	0	.	p	.	0	G134C	NONSYN	400	402	GGT	574	576	TGT	29;29;28	T;G;T	29;29;28	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	572	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1578	19.4	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1144	1146	TTG	24;23;23	T;T;G	24;23;23	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	572	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1578	19.4	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1354	1356	ACG	7;8;7	A;C;G	7;8;7	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	646	mdtL	1176	1176	98.38	mdtL.l15.c4.ctg.1	1611	21.5	0	.	p	.	0	A185S	NONSYN	553	555	GCC	753	755	TCC	13;13;14	T;C;C	13;13;14	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	414	mdtN	1032	1032	98.06	mdtN.l6.c30.ctg.1	1494	14.8	0	.	p	.	0	V119I	NONSYN	355	357	GTT	589	591	ATT	11;11;11	A;T;T	11;11;11	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1000	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2479	21.6	0	.	p	.	0	V11M	NONSYN	31	33	GTG	204	206	ATG	24;24;24	A;T;G	24;24;24	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1000	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2479	21.6	0	.	p	.	0	T33I	NONSYN	97	99	ACC	270	272	ATC	18;18;19	A;T;C	18;18;19	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1000	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2479	21.6	0	.	p	.	0	C116R	NONSYN	346	348	TGC	519	521	CGC	32;30;30	C;G;C	32;30;30	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1000	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2479	21.6	0	.	p	.	0	N238S	NONSYN	712	714	AAC	885	887	AGC	19;19;20	A;G;C	19;18;20	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1000	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2479	21.6	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1086	1088	GTG	12;13;13	G;T;G	12;12;13	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1000	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2479	21.6	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1149	1151	AAC	10;10;9	A;A;C	10;9;9	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1000	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2479	21.6	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1194	1196	GTC	14;14;14	G;T;C	13;14;14	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1000	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2479	21.6	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1224	1226	ATA	21;21;21	A;T;A	21;21;21	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1000	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2479	21.6	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1332	1334	TCT	13;13;13	T;C;T	13;13;13	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1000	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2479	21.6	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1719	1721	GCG	28;28;28	G;C;G	28;28;28	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1000	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2479	21.6	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1932	1934	ATC	24;23;23	A;T;C	24;23;22	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	656	mdtP	1467	1462	97.95	mdtP.l15.c30.ctg.1	1535	22.3	0	.	p	.	0	S129A	NONSYN	385	387	TCA	458	460	GCG	22;21;21	G;C;G	21;20;20	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	656	mdtP	1467	1462	97.95	mdtP.l15.c30.ctg.1	1535	22.3	0	.	p	.	0	A187T	NONSYN	559	561	GCC	632	634	ACC	18;18;16	A;C;C	18;18;16	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	656	mdtP	1467	1462	97.95	mdtP.l15.c30.ctg.1	1535	22.3	0	.	p	.	0	H211R	NONSYN	631	633	CAC	704	706	CGC	23;22;22	C;G;C	23;22;22	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	656	mdtP	1467	1462	97.95	mdtP.l15.c30.ctg.1	1535	22.3	0	.	p	.	0	V250A	NONSYN	748	750	GTT	821	823	GCT	22;22;22	G;C;T	20;21;22	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	656	mdtP	1467	1462	97.95	mdtP.l15.c30.ctg.1	1535	22.3	0	.	p	.	0	R278K	NONSYN	832	834	AGA	905	907	AAA	12;12;12	A;A;A	12;12;12	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	656	mdtP	1467	1462	97.95	mdtP.l15.c30.ctg.1	1535	22.3	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	923	925	CGA	18;19;20	C;G;A	18;19;20	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	656	mdtP	1467	1462	97.95	mdtP.l15.c30.ctg.1	1535	22.3	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1088	1090	GCC	15;15;16	G;C;C	15;15;16	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	656	mdtP	1467	1462	97.95	mdtP.l15.c30.ctg.1	1535	22.3	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1100	1102	GAT	20;21;23	G;A;T	20;20;23	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	656	mdtP	1467	1462	97.95	mdtP.l15.c30.ctg.1	1535	22.3	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1517	1519	GCT	7;7;6	G;C;T	7;7;6	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1714	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3837	23.9	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1510	1512	AAG	17;16;16	A;A;G	17;16;16	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1714	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3837	23.9	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2587	2589	CTG	17;19;18	C;T;G	17;18;18	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	90	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	159	15.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1054	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	1994	28.4	0	.	p	.	0	S278N	NONSYN	832	834	AGC	984	986	AAC	21;22;23	A;A;C	21;22;23	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1054	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	1994	28.4	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1530	1532	ATA	28;29;29	A;T;A	28;29;29	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	862	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1684	27.5	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1330	1332	GAT	41;41;42	G;A;T	41;41;42	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	862	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1684	27.5	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1333	1335	CTG	41;42;44	C;T;G	40;42;44	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	332	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1115	15.9	0	.	p	.	0	R27C	NONSYN	79	81	CGT	286	288	TGT	23;24;24	T;G;T	23;24;24	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	332	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1115	15.9	0	.	p	.	0	I117T	NONSYN	349	351	ATC	556	558	ACC	18;17;17	A;C;C	18;17;17	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	332	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1115	15.9	0	.	p	.	0	G187D	NONSYN	559	561	GGC	766	768	GAC	18;18;18	G;A;C	18;18;18	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	332	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1115	15.9	1	SNP	p	R15C	0	.	.	43	45	CGC	250	252	CGC	32;32;30	C;G;C	32;32;30	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	332	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1115	15.9	1	SNP	p	S33R	0	.	.	97	99	AGC	304	306	AGC	24;24;24	A;G;C	24;24;24	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	332	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1115	15.9	1	SNP	p	G131D	0	.	.	391	393	GGC	598	600	GGC	19;19;18	G;G;C	19;18;18	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	332	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1115	15.9	1	SNP	p	R203C	0	.	.	607	609	CGT	814	816	CGT	22;22;22	C;G;T	22;22;22	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	332	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1115	15.9	1	SNP	p	R203L	0	.	.	607	609	CGT	814	816	CGT	22;22;22	C;G;T	22;22;22	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	624	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1511	22.1	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1112	1114	GAG	25;24;25	G;A;G	25;23;25	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	624	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1511	22.1	1	SNP	p	G141E	0	.	.	421	423	GGT	599	601	GGT	32;31;31	G,A;G;T	31,1;30;31	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	624	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1511	22.1	1	SNP	p	G141D	0	.	.	421	423	GGT	599	601	GGT	32;31;31	G,A;G;T	31,1;30;31	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	624	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1511	22.1	1	SNP	p	R154A	0	.	.	460	462	CGT	638	640	CGT	44;44;43	C;G;T	44;44;43	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	624	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1511	22.1	1	SNP	p	R154D	0	.	.	460	462	CGT	638	640	CGT	44;44;43	C;G;T	44;44;43	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1712	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2752	33.4	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1853	1855	GTG	49;49;49	G;T;G	49;49;49	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1712	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2752	33.4	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1880	1882	TCG	51;52;52	T;C;G	46;49;49	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1712	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2752	33.4	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2495	2497	AAC	27;25;25	A;A;C	27;25;25	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1712	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2752	33.4	1	SNP	p	A85T	0	.	.	253	255	GCG	509	511	GCG	22;22;21	G;C;G	22;22;21	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1712	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2752	33.4	1	SNP	p	D111H	0	.	.	331	333	GAT	587	589	GAT	34;32;30	G;A;T	34;32;30	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1712	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2752	33.4	1	SNP	p	S129P	0	.	.	385	387	TCC	641	643	TCC	34;33;33	T;C;C	34;33;33	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	822	parE_1	1893	1893	97.52	parE_1.l15.c4.ctg.1	2178	19.7	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1447	1449	AAC	36;36;36	A,G;A;C	35,1;35;36	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	822	parE_1	1893	1893	97.52	parE_1.l15.c4.ctg.1	2178	19.7	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1456	1458	GAT	34;34;30	G;A;T	34;34;30	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	902	patA	1380	1380	99.78	patA.l6.c30.ctg.1	1846	26.2	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	838	840	CAG	29;29;30	C;A;G	29;29;30	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	902	patA	1380	1380	99.78	patA.l6.c30.ctg.1	1846	26.2	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1312	1314	GAT	43;43;43	G;A;T	43;43;42	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3068	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4480	36.7	1	SNP	p	V146F	0	.	.	436	438	GTT	648	650	GTT	30;31;31	G;T;T	30;31;31	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3068	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4480	36.7	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1749	1751	CAG	42;41;41	C;A;G	42;41;41	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3068	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4480	36.7	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1749	1751	CAG	42;41;41	C;A;G	42;41;41	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3068	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4480	36.7	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1788	1790	CAC	38;38;37	C;A;C	38;37;37	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3068	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4480	36.7	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1797	1799	CGT	33;31;30	C;G;T	33;31;30	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3068	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4480	36.7	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1797	1799	CGT	33;31;30	C;G;T	33;31;30	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3068	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4480	36.7	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1803	1805	TCC	31;30;29	T;C;C	31;30;29	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3068	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4480	36.7	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1809	1811	CTC	25;23;23	C;T;C	25;23;23	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3068	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4480	36.7	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1899	1901	ACC	37;37;39	A;C;C	37;37;39	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3068	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4480	36.7	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1902	1904	CCT	39;38;40	C,T;C;T,C	38,1;38;39,1	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3068	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4480	36.7	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2271	2273	CGT	86;85;85	C;G;T	86;84;84	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1155	188.0	0	.	n	.	0	A226G	SNP	226	226	A	381	381	G	244	G	243	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1155	188.0	1	SNP	n	A794G	0	.	.	794	794	A	949	949	A	195	A	190	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1155	188.0	1	SNP	n	A794T	0	.	.	794	794	A	949	949	A	195	A	190	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1155	188.0	1	SNP	n	G926A	0	.	.	926	926	G	1081	1081	G	205	G	204	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1155	188.0	1	SNP	n	G926C	0	.	.	926	926	G	1081	1081	G	205	G	204	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1155	188.0	1	SNP	n	G926T	0	.	.	926	926	G	1081	1081	G	205	G	204	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1155	188.0	0	HET	.	.	.	A79G	.	79	79	A	234	234	A	193	A,G	144,46	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1155	188.0	0	HET	.	.	.	C719T	.	719	719	C	874	874	C	211	C,T	116,95	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1155	188.0	0	HET	.	.	.	T273A	.	273	273	T	428	428	T	217	T,A	164,50	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1155	188.0	0	HET	.	.	.	C183T	.	183	183	C	338	338	C	207	C,T	141,65	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1155	188.0	0	HET	.	.	.	T90C	.	90	90	T	245	245	T	194	T,C	144,45	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1155	188.0	0	HET	.	.	.	A250T,C	.	250	250	A	405	405	A	230	A,T,C	170,58,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1155	188.0	0	HET	.	.	.	G474A	.	474	474	G	629	629	G	212	G,A	152,60	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1155	188.0	0	HET	.	.	.	A253T	.	253	253	A	408	408	A	230	A,T	170,58	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1155	188.0	0	HET	.	.	.	C194T	.	194	194	C	349	349	C	211	C,T	169,40	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	519	100.0	rrsB+.l15.c17.ctg.2	533	259.4	1	SNP	n	A1519T	0	.	.	1519	1519	A	496	496	A	213	A,C	211,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	519	100.0	rrsB+.l15.c17.ctg.2	533	259.4	1	SNP	n	A1519G	0	.	.	1519	1519	A	496	496	A	213	A,C	211,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	519	100.0	rrsB+.l15.c17.ctg.2	533	259.4	1	SNP	n	A1519C	0	.	.	1519	1519	A	496	496	A	213	A,C	211,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	519	100.0	rrsB+.l15.c17.ctg.2	533	259.4	0	HET	.	.	.	C1038T	.	1038	1038	C	15	15	C	157	C,T	49,39	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	127	100.0	rrsB+.l15.c17.ctg.4	127	37.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	124	95.2	rrsB+.l15.c17.ctg.5	124	29.1	0	.	n	.	0	G1002A	SNP	1002	1002	G	52	52	A	57	A	57	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	124	95.2	rrsB+.l15.c17.ctg.5	124	29.1	0	.	n	.	0	G1006C	SNP	1006	1006	G	56	56	C	57	C	57	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	124	95.2	rrsB+.l15.c17.ctg.5	124	29.1	0	.	n	.	0	T1010C	SNP	1010	1010	T	60	60	C	56	C	56	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	124	95.2	rrsB+.l15.c17.ctg.5	124	29.1	0	.	n	.	0	A1019.	DEL	1019	1019	A	68	68	G	53	G	53	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	124	95.2	rrsB+.l15.c17.ctg.5	124	29.1	0	.	n	.	0	.1023G	INS	1023	1023	T	73	73	G	48	G	48	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	7198	rrsB+	1542	124	95.2	rrsB+.l15.c17.ctg.5	124	29.1	0	HET	.	.	.	C1038T	.	1038	1038	C	88	88	C	27	C,T	0,27	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	308	soxR	465	465	100.0	soxR.l15.c4.ctg.1	845	19.5	1	SNP	p	R20H	0	.	.	58	60	CGC	257	259	CGC	27;27;28	C;G;C	26;26;27	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	308	soxR	465	465	100.0	soxR.l15.c4.ctg.1	845	19.5	1	SNP	p	G121D	0	.	.	361	363	GGT	560	562	GGT	31;29;29	G;G;T	31;29;29	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	136	soxS_1	324	324	99.69	soxS_1.l6.c4.ctg.1	747	9.5	1	SNP	p	A12S	0	.	.	34	36	GCA	201	203	GCA	18;18;17	G;C;A	18;18;17	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	952	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	1951	26.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
